Varamir
Desk
News
Calendar
Pricing
Saved
Search
tickers or companies
⌘K
Start free
· no card
Sign in
EBS compared with PBYI: revenue, margins and what each company keeps, and the suppliers and customers both name
EBS
Emergent BioSolutions Inc.
Change
Mkt cap
Revenue
Revenue
PBYI
Puma Biotechnology, Inc.
Change
Mkt cap
Revenue
Revenue
vs
Compare
EBS
Emergent BioSolutions Inc.
vs
PBYI
Puma Biotechnology, Inc.
Price
Mkt cap
Revenue
Revenue
Change
Change
Revenue flow
Supply chain
Price
Co-movers
Event sensitivity
Earnings history
Save comparison
Copy link
Price
Desk
News
Calendar
Saved
Search
Price
rebased to 0%
1D
1W
1M
3M
YTD
1Y
5Y
1D
1W
1M
3M
YTD
1Y
5Y
EBS, solid
PBYI, dashed
EBS
Emergent BioSolutions Inc.
Change
6.42
▼
−5.73%
· post 5.25
Mkt cap
$330.2M
Revenue
$234M
Q2 FY26
Revenue
$743M
FY25
PBYI
Puma Biotechnology, Inc.
Change
10.42
▼
−0.22%
· post 10.17
Closed
Nov 2 '26
Mkt cap
$538.9M
Revenue
$57M
Q2 FY26
Revenue
$228M
FY25
vs
Compare
Closed
Nov 2 '26
EBS
Emergent BioSolutions Inc.
vs
PBYI
Puma Biotechnology, Inc.
6.42
▼
−5.73%
post 5.25
Price
10.42
▼
−0.22%
post 10.17
$330.2M
Mkt cap
$538.9M
Q2 FY26
$234M
Revenue
$57M
Q2 FY26
FY25
$743M
Revenue
$228M
FY25
Change
Change
EBS
6.42
▼
−5.73%
vs
PBYI
10.42
▼
−0.22%
Closed
Nov 2 '26